Inventory increased 17.1%
Inventory changed +17.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +17.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross profit changed +19.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net income changed +110.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Debt / revenue changed +516 basis points from the comparable as-filed period.
Research & development changed -16.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Total assets changed -15.0% from the comparable as-filed period.
Gross debt changed -12.6% from the comparable as-filed period.
Reported total debt changed -12.6% from the comparable as-filed period.
Receivables / revenue changed -940 basis points from the comparable as-filed period.
Cash / debt changed -689 basis points from the comparable as-filed period.
Working capital / assets changed -424 basis points from the comparable as-filed period.
Current long-term debt changed -12.6% from the comparable as-filed period.
Short-term borrowings changed -12.6% from the comparable as-filed period.
Current assets changed -5.3% from the comparable as-filed period.
Debt / assets changed +111 basis points from the comparable as-filed period.
Net debt changed -5.1% from the comparable as-filed period.
R&D / revenue changed -2 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current ratio changed -5.3% from the comparable as-filed period.
Current liabilities changed -0.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.